copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Joseph C. Papa - Wikipedia Joseph C Papa (born October 1, 1955) is an American businessman and the chairman and chief executive officer (CEO) of Bausch Lomb, a company formed from the initial public offering (IPO) of the eye health business of Bausch Health Companies Inc [1]
Joseph Papa - Emergent BioSolutions Joseph is an experienced healthcare leader who has spent his career championing products that improve patients’ lives and empowering the teams responsible for bringing those products to market
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa . . . "Following a thorough search process, we are pleased to appoint Joe Papa as president and CEO of Emergent,” said Zsolt Harsanyi, Ph D , chairman of the Board of Directors “He is a recognized industry leader with unparalleled experience in all facets of the pharmaceutical and healthcare industry
Joseph Papa | Our People - Water Street Joseph C Papa is spearheading Water Street’s search for its next investment in the specialty pharmaceutical sector Working with Water Street’s team, he is pursuing discussions with founders and leadership teams of businesses that are interested in a partner to advance their goals for growth
Emergent appoints former Bausch + Lomb CEO to head company Emergent BioSolutions said on Wednesday it has named former Bausch + Lomb CEO Joseph Papa to the top job as the company, which makes the opioid overdose reversal drug Narcan, aims to return to
Joseph Papa: Board of Directors - Milestone Pharma Joseph Papa has over 35 years of experience in the pharmaceutical, healthcare and specialty pharmaceutical industries Since February 2024, he has served as Chief Executive Officer of Emergent BioSolutions (NYSE: EBS)
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Joseph Papa has over 35 years of experience in the pharmaceutical, healthcare and specialty pharmaceutical industries Since February 2024, he has served as Chief Executive Officer of Emergent
Joseph Papa | Candel Therapeutics Joseph Papa has more than 35 years of experience in the pharmaceutical, health care and specialty pharmaceutical industries, including more than 20 years of branded prescription drug experience In July 2022, he stepped down as chair of Bausch + Lomb’s Board and will remain CEO until his successor is appointed
Joseph Papa | Kellogg Alumni In May 2016, Joseph Papa ’83 was a well-known and highly successful business leader in the pharmaceutical industry Harvard Business Review ranked him 47th on its “2014 Best Performing CEOs in the World” list; Barron’s magazine hailed him as one of the world’s best CEOs in 2012, noting that his company, Perrigo, “generated one of